Patents by Inventor Maria Eriksson

Maria Eriksson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230151377
    Abstract: The present invention relates to genetically modified woody plants comprising a heterologous nucleic acid construct comprising a promoter sequence operably linked to a coding sequence encoding a gibberellin 20-oxidase gene product, wherein the promoter is preferentially or specifically expressed in meristematic tissue of said plant. The invention further relates to methods for producing such plants and to certain nucleic acid molecules useful as promoters.
    Type: Application
    Filed: October 30, 2017
    Publication date: May 18, 2023
    Applicant: SWETREE TECHNOLOGIES AB
    Inventors: David JONSÉN, Magnus HERTZBERG, Anna KARLBERG, Thomas MORITZ, Maria ERIKSSON
  • Publication number: 20220251171
    Abstract: The present invention relates to novel fragments of apolipoprotein E (ApoE). These ApoE fragments have a variety of uses including as components of vaccine compositions, particularly vaccines for the prevention or treatment of neurological disorders such as Alzheimer's disease. The ApoE fragments may also be used in screening methods and methods of detection.
    Type: Application
    Filed: June 25, 2020
    Publication date: August 11, 2022
    Inventors: Hiroaki Hagiwara, Kanta Horie, Kunihiko Kanatsu, Yasuharu Ishihara, Yasuaki Goto, Toru Oki, Masafumi Tsuboi, Charlotte Sahlin, Maria Eriksson, Christer Möller
  • Patent number: 10240164
    Abstract: The present invention relates to a method of modulating the density of lignin in a test plant compared to the corresponding lignin density in a wild-type plant cultured under the same conditions, the method comprising modulating the concentration and/or activity of a polypeptide encoded by a core circadian clock gene, wherein modulation of the concentration and/or activity of the polypeptide modulates lignin density in the test plant. The present invention further relates to the use of a genetic construct which is capable of modulating the concentration and/or activity of a polypeptide encoded by a core circadian clock gene, for modulating the density of lignin in a plant, wherein the genetic construct encodes a polypeptide comprising the amino acid sequence substantially as set out in SEQ ID No's: 2 or 4, or a functional variant or fragment thereof.
    Type: Grant
    Filed: December 4, 2013
    Date of Patent: March 26, 2019
    Assignee: British American Tobacco (Investments) Limited
    Inventors: Juan Pablo Sanchez Tamburrino, Kieron Edwards, Maria Eriksson
  • Publication number: 20150307893
    Abstract: The present invention relates to a method of modulating the density of lignin in a test plant compared to the corresponding lignin density in a wild-type plant cultured under the same conditions, the method comprising modulating the concentration and/or activity of a polypeptide encoded by a core circadian clock gene, wherein modulation of the concentration and/or activity of the polypeptide modulates lignin density in the test plant. The present invention further relates to the use of a genetic construct which is capable of modulating the concentration and/or activity of a polypeptide encoded by a core circadian clock gene, for modulating the density of lignin in a plant and use according to either claim 23 or 24, wherein the genetic construct encodes a polypeptide comprising the amino acid sequence substantially as set out in SEQ ID No's: 2 or 4, or a functional variant or fragment thereof.
    Type: Application
    Filed: December 4, 2013
    Publication date: October 29, 2015
    Applicant: c/o British American Tobacco (Investments) Limited
    Inventors: Juan Pablo Sanchez TAMBURRINO, Kieron EDWARDS, Maria ERIKSSON
  • Publication number: 20150033389
    Abstract: The invention relates to a method for producing a genetically modified plant with improved growth properties as compared to a corresponding non-genetically modified wild type plant, said method comprising reducing or deleting the amount or activity of an EBI1 or EBI2 polypeptide in a plant cell, a plant or a part thereof.
    Type: Application
    Filed: March 5, 2013
    Publication date: January 29, 2015
    Inventors: Maria Eriksson, Naoki Takata, Mikael Johansson
  • Patent number: 7807878
    Abstract: Important aims in nearly all tree-breeding programs around the world are to produce plants with increased growth rates and stem volumes, and shorter rotation times. Such trees would yield more biomass per area unit. Here the present inventors have shown that when over-expressing a key regulatory gene in the biosynthesis of the plant hormone gibberellin (GA) in hybrid aspen (Populus tremula×P. tremuloides), improvements in valuable traits such as growth rate and biomass are obtained. In addition, these trees also have longer xylem fibres than unmodified wild type plants. Long fibers are very desirable in the production of strong paper, but it has not (as yet) proved possible to influence this trait by traditional breeding techniques. A further advantage of the present invention is that it may reduce or eliminate the use of growth influencing chemicals in forestry.
    Type: Grant
    Filed: October 30, 2006
    Date of Patent: October 5, 2010
    Assignee: SweTree Technologies AB
    Inventors: Maria Eriksson, Thomas Moritz, Maria Israelsson, Oloff Olsson
  • Publication number: 20070061924
    Abstract: Important aims in nearly all tree-breeding programs around the world are to produce plants with increased growth rates and stem volumes, and shorter rotation times. Such trees would yield more biomass per area unit. Here the present inventors have shown that when over-expressing a key regulatory gene in the biosynthesis of the plant hormone gibberellin (GA) in hybrid aspen (Populus tremula×P. tremuloides), improvements in valuable traits such as growth rate and biomass are obtained. In addition, these trees also have longer xylem fibres than unmodified wild type plants. Long fibres are very desirable in the production of strong paper, but it has not (as yet) proved possible to influence this trait by traditional breeding techniques. A further advantage of the present invention is that it may reduce or eliminate the use of growth influencing chemicals in forestry.
    Type: Application
    Filed: October 30, 2006
    Publication date: March 15, 2007
    Applicant: SweTree Genomics AB
    Inventors: Maria Eriksson, Thomas Moritz, Maria Israelsson, Oloff Olsson
  • Patent number: 7141422
    Abstract: Important aims in nearly all tree-breeding programs around the world are to produce plants with increased growth rates and stem volumes, and shorter rotation times. Such trees would yield more biomass per area unit. Here the present inventors have shown that when over-expressing a key regulatory gene in the biosynthesis of the plant hormone gibberellin (GA) in hybrid aspen (Populus tremula×P. tremuloides), improvements in valuable traits such as growth rate and biomass are obtained. In addition, these trees also have longer xylem fibers than unmodified wild type plants. Long fibres are very desirable in the production of strong paper, but it has not (as yet) proved possible to influence this trait by traditional breeding techniques. A further advantage of the present invention is that it may reduce or eliminate the use of growth influencing chemicals in forestry.
    Type: Grant
    Filed: March 2, 2001
    Date of Patent: November 28, 2006
    Assignee: SweTree Technologies AB
    Inventors: Maria Eriksson, Thomas Moritz, Maria Israelsson, Olof Olsson
  • Publication number: 20050059071
    Abstract: Disclosed herein are point mutations in the LMNA gene that cause HGPS. These mutations activate a cryptic splice site within the LMNA gene, which leads to deletion of part of exon 11 and generation of a mutant Lamin A protein product that is 50 amino acids shorter than the normal protein. In addition to the novel Lamin A variant protein and nucleic acids encoding this variant, methods of using these molecules in detecting biological conditions associated with a LMNA mutation in a subject (e.g., HGPS, arteriosclerosis, and other age-related diseases), methods of treating such conditions, methods of selecting treatments, methods of screening for compounds that influence Lamin A activity, and methods of influencing the expression of LMNA or LMNA variants are also described.
    Type: Application
    Filed: September 17, 2004
    Publication date: March 17, 2005
    Inventors: B. Maria Eriksson, Francis Collins, Leslie Gordon, W. Brown
  • Publication number: 20030172402
    Abstract: Important aims in nearly all tree-breeding programs around the world are to produce plants with increased growth rates and stem volumes, and shorter rotation times. Such trees would yield more biomass per area unit. Here the present inventors have shown that when over-expressing a key regulatory gene in the biosynthesis of the plant hormone gibberellin (GA) in hybrid aspen (Populus tremula x P. tremuloides), improvements in valuable traits such as growth rate and biomass are obtained. In addition, these trees also have longer xylem fibers than unmodified wild type plants. Long fibres are very desirable in the production of strong paper, but it has not (as yet) proved possible to influence this trait by traditional breeding techniques. A further advantage of the present invention is that it may reduce or eliminate the use of growth influencing chemicals in forestry.
    Type: Application
    Filed: January 27, 2003
    Publication date: September 11, 2003
    Inventors: Maria Eriksson, Thomas Moritz, Maria Israelsson, Olof Olsson